Conducting Oncology Clinical Trials in Africa II: ACTC Informational Session

Timing of response to venetoclax combination treatment in older patients with acute myeloid leukaemia

CheckMate 227 three-year update: Nivolumab plus ipilimumab versus chemo as first-line treatment for advanced NSCLC

Conducting Oncology Clinical Trials in Africa II: Practical steps for conducting clinical trials in Africa

ASCO 2020: Latest developments in EGFR-mutated non-small cell lung cancer

Ensuring quality care for breast cancer patients globally

Venetoclax with bortezomib and dexamethasone in relapsed/refractory multiple myeloma

KRd vs VRd for initial therapy of newly diagnosed multiple myeloma

Teclistamab for patients with heavily pretreated relapsed or refractory multiple myeloma

E2108: Systemic therapy plus early local therapy versus systemic therapy alone in women with de novo stage IV breast cancer

KEYNOTE-604: Pembrolizumab plus etoposide and platinum as a first-line therapy for extensive-stage small-cell lung cancer

Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and Cancer Consortium (CCC19)